⌘K

Login Start Free

Home/Insiders/Turka Laurence A.

TL

SEC Insider//CIK 0001800952

Turka Laurence A.

CIK 00018009521 companyCAMBRIDGE, MA

Transactions

13

Companies

1

Filings

4

CIK

0001800952

Recent Transactions

13 trades

Sale
Rubius Therapeutics, Inc.
Common Stock
2023-01-31$0.24/sh−2,593→ 18,391 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-31+8,625→ 20,984 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-31−8,625→ 25,875 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-29+7,438→ 12,359 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-29−7,438→ 14,874 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2022-02-01$6.57/sh−2,517→ 4,921 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-31+34,500→ 34,500 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-31+143,750→ 143,750 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-29−7,438→ 22,312 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2022-01-29+7,438→ 7,438 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2021-01-29+29,750→ 29,750 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-29+131,250→ 131,250 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-31+350,000→ 350,000 total

Companies

1

Rubius Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

4

Address

C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300

CAMBRIDGE, MA, 02139

View on SEC.gov